The AstraZeneca vaccine/Image Source: CNN
The disclosure was made by the Commissioner for Health, Prof. Akin Abayomi in a statement while giving an update on the coronavirus vaccination process in the state.
He said that after the administration of the first dose of the AstraZeneca vaccine to 257,756 persons, just a few of the individuals experienced what is called adverse events following immunization (AEFI) or adverse event of special interest (AESI).
READ ALSO: AstraZeneca: Australia Scraps Covid-19 Vaccine Roll-Out Targets Over Expert Advice
Prof. Akin Abayomi/Image Source: Premium Times Nigeria
The above adverse effects are characterized by pain at the injection site, fever or body pains lasting 24 to 48 hours, and anaphylactic shock.
"We are being extremely diligent for blood coagulation disorders in view of the prevailing international scientific attention to the possibility of increased risk of developing blood clotting disorders, and two cases are being investigated.
"It is important in the interest of scientific knowledge to be able to attribute any blood clotting problems directly to the administration of the vaccine.
"The Lagos State Government has robust surveillance systems to effectively monitor and track untoward events and I would like to urge anyone who experiences any adverse events to call the number of the LGA Disease Surveillance Notification written in front of the vaccination card so that such cases can be thoroughly investigated and monitored."
0 Comment(s)